Strand AI GTM brain

Strand AI predicts missing spatial protein data from pathology slides for pharmaceutical and translational research teams.

category

Computational spatial biology

market profile

  • text: Biopharma cohorts frequently lack biological assays that could inform biomarkers and patient stratification.
  • text: Lattice predicts virtual protein channels from digitized H&E slides and returns cohort-level analysis.

personas

  • title: Translational medicine or biomarker lead
    pains:
    • Archived trial samples lack the spatial assays needed to investigate response
    • Limited tissue and assay budgets constrain biomarker discovery
  • title: Computational pathology lead
    pains:
    • Whole-slide images contain morphology but missing molecular measurements
    • Predictions must be validated across tissues and sites
  • title: Clinical development leader
    pains:
    • Weak patient stratification can undermine trial design
    • Retrospective cohort work competes with scarce lab capacity

icp

  • text: Pharmaceutical and biotechnology companies with oncology trials and digitized H&E archives are likely fits.
  • text: Academic medical centers and research groups with retrospective cohorts and spatial biomarker questions are potential partners.

message pillars

  • text: Derive spatial protein maps from existing slides.
  • text: Preserve scarce tissue by predicting computationally.
  • text: Scale retrospective studies to whole archives.
  • text: Provide a managed analysis service.

objections

  • objection: How well do predicted markers reflect actual biology?
    response: Request marker-level and cohort-specific validation against measured multiplex data before relying on the outputs.
  • objection: Our slides cannot leave our institution.
    response: Strand says it can deploy and run Lattice in the customer's environment for restricted cohorts.

competitors

  • name: Tempus AI
    why: Multimodal patient data and computational pathology compete for biopharma research work.
  • name: Enable Medicine
    why: Spatial biology analysis is an alternative for tissue and biomarker research.

influencers

  • name: Yue Dai
    url: https://www.ycombinator.com/founders/yue-dai
    why: CEO and cofounder with foundation-model experience.

keywords

  • spatial proteomics H&E
  • virtual multiplex immunofluorescence
  • AI pathology biomarker discovery
  • patient stratification oncology
  • spatial biology retrospective cohorts
  • predict protein expression pathology

voice

  • Scientifically specific
  • Practical and research oriented

signals

  • text: An oncology program is revisiting archived trial slides for response biomarkers.
  • text: A research team is planning costly multiplex assays but needs to triage samples first.

stack

  • H&E whole-slide images
  • multiplex immunofluorescence

pricing

model: unknown

motion

hybrid

channels

  • LinkedIn
  • YC launch
  • research partnerships
  • technical documentation

confidence

medium

Founders

  • name: Yue Dai
    title: Founder/CEO
    role: CEO
    bio: Cofounder & CEO at Strand AI ex-Pathos AI, Enable Medicine, Microsoft Research, Element AI. Trained foundation models for biology on the largest patient dataset in existence.
  • name: Oded Falik
    title: Founder/CTO
    role: CTO
    bio: Cofounder & CTO at Strand AI Ex-Enable Medicine Building foundation models to enrich biology data and improve patient outcomes. Oded Falik, CTO, was the Tech Lead for Enable Medicine's spatial biology platform, scaling to 12B+ single-cell annotations and petabyte-scale pipelines. Programming since 8 years old, published first app on iOS app store at 11 years old.

Back to YC companies